BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu DX, Li PP, Guo JP, Li LL, Guo B, Jiao HB, Wu JH, Chen JM. Exosomes derived from HBV-associated liver cancer promote chemoresistance by upregulating chaperone-mediated autophagy. Oncol Lett 2019;17:323-31. [PMID: 30655770 DOI: 10.3892/ol.2018.9584] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Zhang Y, Luo B. Effects of Exosomal Viral Components on the Tumor Microenvironment. Cancers 2022;14:3552. [DOI: 10.3390/cancers14143552] [Reference Citation Analysis]
2 Console L, Scalise M. Extracellular Vesicles and Cell Pathways Involved in Cancer Chemoresistance. Life 2022;12:618. [DOI: 10.3390/life12050618] [Reference Citation Analysis]
3 Wang X, Yi H, Tu J, Fan W, Wu J, Wang L, Li X, Yan J, Huang H, Huang R. Comprehensive Analysis Identified ASF1B as an Independent Prognostic Factor for HBV-Infected Hepatocellular Carcinoma. Front Oncol 2022;12:838845. [PMID: 35280822 DOI: 10.3389/fonc.2022.838845] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wei ZQ, Zhang YW. Transcatheter arterial chemoembolization followed by surgical resection for hepatocellular carcinoma: a focus on its controversies and screening of patients most likely to benefit. Chin Med J (Engl) 2021;134:2275-86. [PMID: 34593696 DOI: 10.1097/CM9.0000000000001767] [Reference Citation Analysis]
5 Yin W, Xiang D, Wang T, Zhang Y, Pham CV, Zhou S, Jiang G, Hou Y, Zhu Y, Han Y, Qiao L, Tran PH, Duan W. The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells. Sci Rep 2021;11:10791. [PMID: 34031441 DOI: 10.1038/s41598-021-89931-9] [Reference Citation Analysis]
6 Jiang Y, Han Q, Zhao H, Zhang J. The Mechanisms of HBV-Induced Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:435-50. [PMID: 34046368 DOI: 10.2147/JHC.S307962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Suares A, Medina MV, Coso O. Autophagy in Viral Development and Progression of Cancer. Front Oncol 2021;11:603224. [PMID: 33763351 DOI: 10.3389/fonc.2021.603224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Colletti M, Ceglie D, Di Giannatale A, Nazio F. Autophagy and Exosomes Relationship in Cancer: Friends or Foes? Front Cell Dev Biol 2020;8:614178. [PMID: 33511121 DOI: 10.3389/fcell.2020.614178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Mostafazadeh M, Samadi N, Kahroba H, Baradaran B, Haiaty S, Nouri M. Potential roles and prognostic significance of exosomes in cancer drug resistance. Cell Biosci 2021;11:1. [PMID: 33407894 DOI: 10.1186/s13578-020-00515-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
10 Liao Z, Wang B, Liu W, Xu Q, Hou L, Song J, Guo Q, Li N. Dysfunction of chaperone-mediated autophagy in human diseases. Mol Cell Biochem 2021;476:1439-54. [PMID: 33389491 DOI: 10.1007/s11010-020-04006-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Martins ST, Alves LR. Extracellular Vesicles in Viral Infections: Two Sides of the Same Coin? Front Cell Infect Microbiol 2020;10:593170. [PMID: 33335862 DOI: 10.3389/fcimb.2020.593170] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Ouyang Y, Tang Y, Fu L, Peng S, Wu W, Tan D, Fu X. Exosomes secreted by chronic hepatitis B patients with PNALT and liver inflammation grade ≥ A2 promoted the progression of liver cancer by transferring miR-25-3p to inhibit the co-expression of TCF21 and HHIP. Cell Prolif 2020;53:e12833. [PMID: 32525231 DOI: 10.1111/cpr.12833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
13 Santos P, Almeida F. Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance. Cells 2020;9:E1450. [PMID: 32545155 DOI: 10.3390/cells9061450] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
14 Hou T, Fan Y, Dan W, Liu B, Wang Z, Zeng J, Li L. Chaperone-mediated autophagy in cancer: Advances from bench to bedside. Histol Histopathol 2020;35:637-44. [PMID: 31965560 DOI: 10.14670/HH-18-202] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Arias E, Cuervo AM. Pros and Cons of Chaperone-Mediated Autophagy in Cancer Biology. Trends Endocrinol Metab 2020;31:53-66. [PMID: 31699565 DOI: 10.1016/j.tem.2019.09.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
16 Magalhaes I, Yogev O, Mattsson J, Schurich A. The Metabolic Profile of Tumor and Virally Infected Cells Shapes Their Microenvironment Counteracting T Cell Immunity. Front Immunol 2019;10:2309. [PMID: 31636636 DOI: 10.3389/fimmu.2019.02309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]